Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abatacept and Cyclophosphamide for GVHD Prophylaxis
NCT03680092Phase 2Completed
- Start
- Nov 2019
- Primary completion
- Jun 2023
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of abatacept in graft-versus-host disease (GVHD). Started Nov 2019; status: completed.
02
Drugs
abatacept
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT03680092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03680092.